CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance. (linkinghub.elsevier.com)

Authors: Watterson A … Coelho MA Journal: Cell Reports Medicine Published: 2026-01-20 DOI: https://doi.org/10.1016/j.xcrm.2025.102565